Data Sheet 6_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Flow of included patients through the trial. by Chao Yang (174810)

“…</p><p>Results</p><p>There is a nonlinear association between the HAR and mortality within 28 days after intensive care unit admission. When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Data Sheet 10_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 8_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 1_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 11_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Cox proportional hazards modeling. by Chao Yang (174810)

“…</p><p>Results</p><p>There is a nonlinear association between the HAR and mortality within 28 days after intensive care unit admission. When the HAR was lower than 0.13, mortality within 28 days after ICU admission decreased significantly as the HAR increased. …”

Supplementary file 1_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.xlsx by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 4_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 7_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 3_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Data Sheet 2_Global, regional, and national burdens of congenital heart anomalies from 1990 to 2021, and projections to 2050.pdf by Erdengqieqieke Ye (19542808)

“…</p>Results<p>CHA prevalence and incidence remained stable, with higher incidence in lower SDI regions. Mortality rates, age-standardized DALYs, and YLLs consistently decreased, with males showing higher rates, particularly in low SDI areas. …”

Image 1_iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis.tif by Jingyu Zhao (2371618)

“…Its MIC against Cryptococcus was over eight times lower than conventional AmB, significantly reducing fungal burden in the mouse brain and lowering serum inflammatory factors.…”

Image 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. We performed a series of behavioral tests on male mice because obesity is often associated with cognitive and emotional impairment. …”

Image 4_Beta-hydroxybutyrate (BHB) elicits concentration-dependent anti-inflammatory effects on microglial cells which are reversible by blocking its monocarboxylate (MCT) importer... by Chase Garcia (21803576)

“…</p>Results<p>At this concentration, BHB significantly and concentration-dependently decreased the following: 1) inflammatory cytokine expression (IL-6, TNF-α, and IL-1β), 2) inflammatory morphological changes, and 3) activation of p-ERK and p-p38MAPK, which are key pathways involved in microglial inflammation. …”

Table 2_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. We performed a series of behavioral tests on male mice because obesity is often associated with cognitive and emotional impairment. …”

Data Sheet 1_Increased epicardial tissue and reduced TAPSE and MAPSE scores in borderline personality disorders. Early indicators for cardiovascular risk?.pdf by Charlotte F. M. Schaefer (21466880)

“…Additionally, significant decreases in right (TAPSE) and left (MAPSE) ventricular function, albeit within the normal range, were measured in BPD patients. …”

Table 1_A unique polygenic mouse model of obesity exhibits a distinct immunological profile that may offer protection against systemic inflammation, diabetes, and behavioral impair... by Ulrike Gimsa (9730208)

“…Unlike other mouse lines, DU6 mice do not develop diabetes despite significant obesity. We performed a series of behavioral tests on male mice because obesity is often associated with cognitive and emotional impairment. …”

Image 2_Beta-hydroxybutyrate (BHB) elicits concentration-dependent anti-inflammatory effects on microglial cells which are reversible by blocking its monocarboxylate (MCT) importer... by Chase Garcia (21803576)

“…</p>Results<p>At this concentration, BHB significantly and concentration-dependently decreased the following: 1) inflammatory cytokine expression (IL-6, TNF-α, and IL-1β), 2) inflammatory morphological changes, and 3) activation of p-ERK and p-p38MAPK, which are key pathways involved in microglial inflammation. …”

Image 1_Beta-hydroxybutyrate (BHB) elicits concentration-dependent anti-inflammatory effects on microglial cells which are reversible by blocking its monocarboxylate (MCT) importer... by Chase Garcia (21803576)

“…</p>Results<p>At this concentration, BHB significantly and concentration-dependently decreased the following: 1) inflammatory cytokine expression (IL-6, TNF-α, and IL-1β), 2) inflammatory morphological changes, and 3) activation of p-ERK and p-p38MAPK, which are key pathways involved in microglial inflammation. …”